Refine by
Data Driven Decision Articles & Analysis
10 news found
As the CEO of a feed or pet food company, you face daily challenges involving margin alignment, data accuracy, logistic challenges, and legislative compliance. Simultaneously, you're seeking opportunities for growth, increased profitability, maintaining a robust reputation, streamlining operations, and safeguarding your company's market standing amidst unstable market ...
ByBESTMIX
Emerging trends in the biopharma industry include new developments in cancer treatments, advances in gene therapy, and more data-driven decision-making. As a leader in the sector, it’s important to be aware of these developments to make informed decisions about your organization’s direction. ...
"The extension of our collaboration with CytoReason will build upon our existing data science capabilities, and further enhance our ability to make data-driven decisions across our portfolio," said Mikael Dolsten, M.D., Ph.D., Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer. ...
CytoReason's AI platform will use its disease model, along with clinical data from the Japanese pharmaceutical company, to help it gain a better understanding of how its drug behaves on a molecular level, relative to similar drugs on the market. ...
With these resources and testing components in place, we're able to make data-driven decisions and policies to support the health and safety of our students and community." ...
Levy has devoted her career to developing systems to support data-driven decision-making in cancer care and research. She has contributed to more than 90 publications on cancer and led the development of My Cancer Genome, an international knowledge resource for precision medicine that provides accessible information to patients and physicians ...
” Intelligencia is an AI-driven technology company that focuses on minimizing the risk of drug development and enabling external innovation. ...
With CytoReason's proprietary database and AI-led platform, pharma and biotech companies make data-driven decisions in a fraction of the time and cost. To date, six of the world's top ten pharma companies use CytoReason's technology to bring the right drug, to the right patient, at the right price. ...
Leveraging an extensive library of both public and proprietary molecular data, CytoReason's technology allows scientists to gain critical information on the body's functioning, and to address diseases such as IBD at the cellular level. ...
The major challenge for the client was data getting corrupt despite performing an extensive data standardization activity. With the involvement of multiple stakeholders at various locations, without defined data inputs rules the data quality eroded in no time. Enventure will provide Master Data Governance as a ...